Adam R. Levy Sells 4,000 Shares of NEXGEL, Inc. (NASDAQ:NXGL) Stock

NEXGEL, Inc. (NASDAQ:NXGL) CEO Adam R. Levy sold 4,000 shares of NEXGEL stock in a transaction on Tuesday, April 1st. The shares were sold at an average price of $3.01, for a total value of $12,040.00. Following the completion of the transaction, the chief executive officer now owns 370,284 shares in the company, valued at $1,114,554.84. This represents a 1.07 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink.

NEXGEL Price Performance

Shares of NXGL stock opened at $2.85 on Thursday. The stock’s 50-day moving average is $3.16 and its 200 day moving average is $3.28. NEXGEL, Inc. has a 1-year low of $1.84 and a 1-year high of $5.10. The company has a debt-to-equity ratio of 0.19, a current ratio of 1.51 and a quick ratio of 0.93. The company has a market cap of $19.35 million, a P/E ratio of -4.91 and a beta of 0.62.

NEXGEL (NASDAQ:NXGL) last released its quarterly earnings results on Monday, March 24th. The company reported ($0.08) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.10) by $0.02. The business had revenue of $3.04 million for the quarter, compared to analysts’ expectations of $2.99 million. NEXGEL had a negative net margin of 52.60% and a negative return on equity of 71.19%.

Hedge Funds Weigh In On NEXGEL

Several institutional investors and hedge funds have recently bought and sold shares of NXGL. Renaissance Technologies LLC increased its position in shares of NEXGEL by 456.4% during the fourth quarter. Renaissance Technologies LLC now owns 158,331 shares of the company’s stock worth $706,000 after purchasing an additional 129,876 shares in the last quarter. Two Sigma Securities LLC purchased a new position in NEXGEL during the 4th quarter worth $54,000. IFP Advisors Inc acquired a new position in NEXGEL during the 4th quarter valued at about $49,000. Virtu Financial LLC purchased a new stake in NEXGEL in the fourth quarter valued at about $48,000. Finally, Geode Capital Management LLC boosted its holdings in NEXGEL by 5.8% in the fourth quarter. Geode Capital Management LLC now owns 60,142 shares of the company’s stock worth $268,000 after acquiring an additional 3,302 shares in the last quarter. 2.21% of the stock is owned by hedge funds and other institutional investors.

NEXGEL Company Profile

NEXGEL, Inc manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels. Its products are used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company was formerly known as AquaMed Technologies, Inc and changed its name to NEXGEL, Inc in November 2019.